Literature DB >> 17848278

Multidisciplinary management of laryngeal carcinoma.

William M Mendenhall1, Anthony A Mancuso, Russell W Hinerman, Robert S Malyapa, John W Werning, Robert J Amdur, Douglas B Villaret.   

Abstract

The management of head and neck cancer has evolved into a multidisciplinary approach in which patients are evaluated before treatment and decisions depend on prospective multi-institutional trials, as well as retrospective outcome studies. The choice of one or more modalities to use in a given case varies with the tumor site and extent, as exemplified in the treatment of laryngeal squamous cell carcinomas. The goals of treatment include cure, laryngeal voice preservation, voice quality, optimal swallowing, and minimal xerostomia. Treatment options include transoral laser excision, radiotherapy (both definitive and postoperative), open partial laryngectomy, total laryngectomy, and neck dissection. The likelihood of local control and preservation of laryngeal function is related to tumor volume. Patients who have a relatively high risk of local recurrence undergo follow-up computed tomography scans every 3-4 months for the first 2 years after radiotherapy. Patients with suspicious findings on computed tomography might benefit from fluorodeoxyglucose positron emission tomography to differentiate post-radiotherapy changes from tumor.

Entities:  

Mesh:

Year:  2007        PMID: 17848278     DOI: 10.1016/j.ijrobp.2007.05.036

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

Review 1.  Current trends in initial management of laryngeal cancer: the declining use of open surgery.

Authors:  Carl E Silver; Jonathan J Beitler; Ashok R Shaha; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-14       Impact factor: 2.503

2.  Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma.

Authors:  Jin Ye; Hui Liu; Yanming Hu; Peng Li; Gehua Zhang; Yuan Li
Journal:  Virchows Arch       Date:  2012-11-20       Impact factor: 4.064

3.  Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions.

Authors:  Ekin Ermiş; Mark Teo; Karen E Dyker; Chris Fosker; Mehmet Sen; Robin Jd Prestwich
Journal:  Radiat Oncol       Date:  2015-09-23       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.